Jaguar Health Sets Key Investor Webcast Amid Delayed First Quarter Financial Filing
San Francisco, Wednesday, 20 May 2026.
Jaguar Health will host a May 26 webcast to discuss Q1 2026 financials, following a brief filing delay caused by compiling significant, material subsequent-event transactions.
Navigating Filing Delays and Upcoming Disclosures
Expanding on this filing delay, Jaguar Health, Inc. (NASDAQ: JAGX) officially notified the Securities and Exchange Commission on May 18, 2026, via a Rule 12b-25 submission, that it required additional time to finalize its first-quarter Form 10-Q [4]. The San Francisco-based pharmaceutical company emphasized that compiling data related to these material subsequent events necessitated the extension [2][4]. Chief Financial Officer Carol Lizak, who signed the official notification, committed the firm to filing the comprehensive report no later than the fifth calendar day following the original due date, establishing a new target deadline of May 23, 2026 [4].